Graham Capital Management, L.P. Glaukos Corp Transaction History

Graham Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $260,086 - $371,845	4,369 New	4,369 $347,000
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $807,093 - $1.14 Million	19,772 Added 132.12%	34,737 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$46.84 - $58.49 $758,948 - $947,713	-16,203 Reduced 51.99%	14,965 $796,000
Q2 2022 Aug 15, 2022	BUY	$34.86 - $63.77 $760,296 - $1.39 Million	21,810 Added 233.06%	31,168 $1.42 Million
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $414,840 - $541,079	9,358 New	9,358 $541,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.73B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.